Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of British Columbia

$27,000.00

Utilizing spatial multi-omics to characterize the tumor microenvironment of breast ductal carcinoma in situ

FY 2025-26

Summary
Breast ductal carcinoma in-situ (DCIS) is an early form of breast cancer that has not yet spread outside the breast milk ducts. DCIS makes up about 20% of all new breast cancer diagnosis. In Canada, the main treatment is surgery to remove part of the breast with DCIS. This surgery is performed because individuals with untreated DCIS have around 25% higher chance of developing invasive breast cancer later on that can spread beyond the ducts. Currently, pathologists cannot reliably predict which DCIS cases will become invasive cancer. As a result, most patients are treated with surgery even though only some of them will ever develop invasive disease. This means most patients undergo unnecessary surgery because we do not have a reliable way to determine who will develop invasive cancer post-surgery, and most patients are faced with tough choices and uncertainty. Our project aims to fill this gap by developing better tools to help doctors guide treatment decisions. Firstly, we will look at how cancer cells and immune cells interact and whether there are any patterns in how these cells are arranged that is linked to different outcomes. Furthermore, we will study how cancer cells in DCIS “communicate” with each other and if these communication patterns are associated with specific outcomes for cases that turn into invasive cancer post-surgery. This study can enable us to understand the underlying mechanisms driving breast cancer that we are currently unable to perceive with existing tools. Ultimately, this research project is the first step towards our long-term goal of developing a biomarker that can be used to spare patients with DCIS from unnecessary surgery
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573271
Name
Arora Puneet K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Utilizing spatial multi-omics to characterize the tumor microenvironment of breast ductal carcinoma in situ
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Carcinogenesis; Cell Sociology; Cell-Cell Communication; Ductal Carcinoma In-Situ; Immunofluorescence; Multiplex Imaging; Spatial Profiling; Spatial Proteomics; Spatial Transcriptomics; Tumor Microenvironment
Abstract
Breast ductal carcinoma in-situ (DCIS) is an early form of breast cancer that has not yet spread outside the breast milk ducts. DCIS makes up about 20% of all new breast cancer diagnosis. In Canada, the main treatment is surgery to remove part of the breast with DCIS. This surgery is performed because individuals with untreated DCIS have around 25% higher chance of developing invasive breast cancer later on that can spread beyond the ducts. Currently, pathologists cannot reliably predict which DCIS cases will become invasive cancer. As a result, most patients are treated with surgery even though only some of them will ever develop invasive disease. This means most patients undergo unnecessary surgery because we do not have a reliable way to determine who will develop invasive cancer post-surgery, and most patients are faced with tough choices and uncertainty. Our project aims to fill this gap by developing better tools to help doctors guide treatment decisions. Firstly, we will look at how cancer cells and immune cells interact and whether there are any patterns in how these cells are arranged that is linked to different outcomes. Furthermore, we will study how cancer cells in DCIS “communicate” with each other and if these communication patterns are associated with specific outcomes for cases that turn into invasive cancer post-surgery. This study can enable us to understand the underlying mechanisms driving breast cancer that we are currently unable to perceive with existing tools. Ultimately, this research project is the first step towards our long-term goal of developing a biomarker that can be used to spare patients with DCIS from unnecessary surgery
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arora, Puneet K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~